Neuland Laboratories Limited Return on Equity (ROE) for the year ending March 31, 2025: 17.06%

Neuland Laboratories Limited Return on Equity (ROE) is 17.06% for the year ending March 31, 2025, a -27.08% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Neuland Laboratories Limited Return on Equity (ROE) for the year ending March 31, 2024 was 23.39%, a 42.22% change year over year.
  • Neuland Laboratories Limited Return on Equity (ROE) for the year ending March 31, 2023 was 16.45%, a 116.62% change year over year.
  • Neuland Laboratories Limited Return on Equity (ROE) for the year ending March 31, 2022 was 7.59%, a -25.94% change year over year.
  • Neuland Laboratories Limited Return on Equity (ROE) for the year ending March 31, 2021 was 10.25%, a 349.02% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share